Article History
Received: 11 April 2019
Accepted: 2 August 2019
First Online: 26 August 2019
Compliance with ethical standards
:
: Dr. Puig-Carrion has no financial conflicts of interest. Dr. Alex Reyentovich has received research support (Pfizer and Eidos Therapeutics) and consulting fees (Pfizer and Alnylam Pharmaceutical). Dr. Stuart Katz has received research support from Pfizer and Eidos Therapeutics.